Skip to main content
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. — Investor Relations & Filings

Ticker · SLS ISIN · US81642T2096 LEI · 549300VZIH50VYURLQ98 US Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2015-04-09 Regulatory Filings
Country US United States of America
Listing US SLS

About SELLAS Life Sciences Group, Inc.

https://www.sellaslifesciences.com/

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's core activity involves advancing its pipeline of cancer immunotherapies, which are designed to utilize the patient's immune system to combat various malignancies. Its development programs aim to address significant unmet medical needs in oncology by creating new treatment options for cancer patients.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content focuses on an FDA Warning Letter received by the company regarding regulatory compliance issues. It does not contain financial statements or detailed financial analysis. The document is not an annual or quarterly report, nor is it a transcript, presentation, or voting result. It is a regulatory announcement about a significant event affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-04-09 English
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 13, 2015, by Galena Biopharma, Inc. The content describes the entry into a material definitive agreement related to a public offering of common stock and warrants, including underwriting details, pricing, and terms. It also includes information about the adjustment of outstanding warrants and other related events. The document is focused on a financing transaction and capital raising activity. There are no financial statements or detailed financial performance data included, and the primary subject is the announcement of a capital raising event. Therefore, this filing fits the category of Capital/Financing Update (CAP). The document length is 8936 characters, which is substantive and detailed, supporting a confident classification.
2015-03-14 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus supplement and prospectus related to a securities offering, specifically a shelf registration under Rule 424(b)(5) for common stock and warrants. It includes detailed information about the offering terms, underwriting, risk factors, use of proceeds, and company overview. This type of document is used to inform investors about a capital raising event and the securities being offered. It is not a financial report, earnings release, management discussion, or any other type of regulatory filing related to financial results or governance. The document is clearly a capital/financing update related to a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-03-13 English
424B2
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement and accompanying prospectus related to an offering of common stock and warrants. It references Rule 424(b)(2) and a shelf registration statement (Form S-3). The content includes detailed terms of the securities offering, risk factors, use of proceeds, underwriting details, and company overview. This type of document is a capital raising filing, specifically a prospectus supplement used in securities offerings to investors. It is not an annual report, earnings release, or any other financial report. It is clearly a Capital/Financing Update filing related to fundraising activities.
2015-03-12 English
10-K/A
Annual Report FY 2014
2015-03-10 English
10-K
Annual Report FY 2014
2015-03-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.